ALXN insider filings
ALEXION PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-07-23. Screen ALXN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ALXN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — ALEXION PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-07-23 | 4 | Carino Tanisha — EVP & CCAO | Disposition to issuer (D): 59,226 @ $0 | EDGAR |
| 2021-07-23 | 4 | Bazarko Daniel — SVP, Controller, CAO | Disposition to issuer (D): 60,207 @ $0 · Disposition to issuer (D): 5,300 (derivative) @ $131.25 · Disposition to issuer (D): 5,111 (derivative) @ $176.80 · Disposition to issuer (D): 3,943 (derivative) @ $180.37 · Disposition to issuer (D): 2,912 (derivative) @ $180.28 | EDGAR |
| 2021-07-23 | 4 | SARIN ARADHANA — EVP, CFO | Disposition to issuer (D): 120,253 @ $0 | EDGAR |
| 2021-07-23 | 4 | Franchini Indrani Lall — EVP, Chief Compliance Officer | Disposition to issuer (D): 116,075 @ $0 · Disposition to issuer (D): 25,165 (derivative) @ $100.14 | EDGAR |
| 2021-07-23 | 4 | ORLOFF JOHN J — EVP, Research & Development | Disposition to issuer (D): 146,511 @ $0 | EDGAR |
| 2021-07-23 | 4 | Brennan David R — Director | Disposition to issuer (D): 20,873 @ $0 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 | EDGAR |
| 2021-07-23 | 4 | Goff Brian — EVP & Chief Commercial Officer | Disposition to issuer (D): 150,832 @ $0 · Disposition to issuer (D): 21,750 (derivative) @ $100.14 | EDGAR |
| 2021-07-23 | 4 | HANTSON LUDWIG — CEO, Director | Disposition to issuer (D): 580,809 @ $0 · Disposition to issuer (D): 56,762 (derivative) @ $118.83 | EDGAR |
| 2021-07-23 | 4 | Rummelt Andreas — Director | Disposition to issuer (D): 28,109 @ $0 · Disposition to issuer (D): 2,785 (derivative) @ $159.70 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 3,425 (derivative) @ $96.35 · Disposition to issuer (D): 3,237 (derivative) @ $85.75 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 | EDGAR |
| 2021-07-23 | 4 | Chiniara Ellen — EVP & Chief Legal Officer | Disposition to issuer (D): 116,850 @ $0 | EDGAR |
| 2021-07-23 | 4 | Mollen John T — Director | Disposition to issuer (D): 15,336 @ $0 · Disposition to issuer (D): 2,785 (derivative) @ $159.70 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 | EDGAR |
| 2021-07-23 | 4 | Nader Francois — Director | Disposition to issuer (D): 13,921 @ $0 | EDGAR |
| 2021-07-23 | 4 | Dunsire Deborah — Director | Disposition to issuer (D): 14,629 @ $0 | EDGAR |
| 2021-07-23 | 4 | Reinsdorf Judith A — Director | Disposition to issuer (D): 14,150 @ $0 | EDGAR |
| 2021-07-23 | 4 | FRIEDMAN PAUL A — Director | Disposition to issuer (D): 12,840 @ $0 | EDGAR |
| 2021-07-23 | 4 | COUGHLIN CHRISTOPHER J — Director | Disposition to issuer (D): 42,347 @ $0 · Disposition to issuer (D): 2,294 (derivative) @ $138.86 · Disposition to issuer (D): 2,706 (derivative) @ $167.97 · Disposition to issuer (D): 2,343 (derivative) @ $155.01 | EDGAR |
| 2021-07-16 | 4 | Carino Tanisha — EVP & CCAO | Grant/award (A): 25,813 @ $0 | EDGAR |
| 2021-07-16 | 4 | Bazarko Daniel — SVP, Controller, CAO | Grant/award (A): 11,060 @ $0 · Grant/award (A): 10,648 @ $0 | EDGAR |
| 2021-07-16 | 4 | SARIN ARADHANA — EVP, CFO | Grant/award (A): 26,812 @ $0 · Grant/award (A): 29,501 @ $0 | EDGAR |
| 2021-07-16 | 4 | Franchini Indrani Lall — EVP, Chief Compliance Officer | Grant/award (A): 26,812 @ $0 · Grant/award (A): 25,813 @ $0 | EDGAR |
| 2021-07-16 | 4 | ORLOFF JOHN J — EVP, Research & Development | Grant/award (A): 30,643 @ $0 · Grant/award (A): 29,501 @ $0 | EDGAR |
| 2021-07-16 | 4 | Goff Brian — EVP & Chief Commercial Officer | Grant/award (A): 30,643 @ $0 · Grant/award (A): 29,501 @ $0 | EDGAR |
| 2021-07-16 | 4 | HANTSON LUDWIG — CEO, Director | Grant/award (A): 120,894 @ $0 · Grant/award (A): 119,847 @ $0 | EDGAR |
| 2021-07-16 | 4 | Chiniara Ellen — EVP & Chief Legal Officer | Grant/award (A): 26,812 @ $0 · Grant/award (A): 27,657 @ $0 | EDGAR |
| 2021-06-09 | 4 | Franchini Indrani Lall — EVP, Chief Compliance Officer | Tax withholding (F): 928 @ $177 | EDGAR |
| 2021-06-09 | 4 | ORLOFF JOHN J — EVP, Research & Development | Tax withholding (F): 1,957 @ $177 | EDGAR |
| 2021-06-09 | 4 | Goff Brian — EVP & Chief Commercial Officer | Tax withholding (F): 1,086 @ $177 | EDGAR |
| 2021-05-24 | 4 | Brennan David R — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 1,374 @ $0 | EDGAR |
| 2021-05-24 | 4 | Rummelt Andreas — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0 | EDGAR |
| 2021-05-24 | 4 | Mollen John T — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0 | EDGAR |
| 2021-05-24 | 4 | Nader Francois — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0 | EDGAR |
| 2021-05-24 | 4 | Dunsire Deborah — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0 | EDGAR |
| 2021-05-24 | 4 | Reinsdorf Judith A — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 673 @ $0 | EDGAR |
| 2021-05-24 | 4 | FRIEDMAN PAUL A — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 533 @ $0 | EDGAR |
| 2021-05-24 | 4 | COUGHLIN CHRISTOPHER J — Director | Grant/award (A): 1,962 @ $0 · Grant/award (A): 729 @ $0 | EDGAR |
| 2021-04-01 | 4 | HANTSON LUDWIG — CEO, Director | Tax withholding (F): 2,332 @ $154.03 | EDGAR |
| 2021-03-02 | 4 | Carino Tanisha — EVP & CCAO | Grant/award (A): 18,033 @ $0 · Tax withholding (F): 722 @ $151.75 | EDGAR |
| 2021-03-02 | 4 | Bazarko Daniel — SVP, Controller, CAO | Grant/award (A): 7,616 @ $0 | EDGAR |
| 2021-03-02 | 4 | SARIN ARADHANA — EVP, CFO | Grant/award (A): 24,473 @ $0 | EDGAR |
| 2021-03-02 | 4 | Franchini Indrani Lall — EVP, Chief Compliance Officer | Grant/award (A): 18,033 @ $0 | EDGAR |
| 2021-03-02 | 4 | ORLOFF JOHN J — EVP, Research & Development | Grant/award (A): 24,473 @ $0 | EDGAR |
| 2021-03-02 | 4 | Goff Brian — EVP & Chief Commercial Officer | Grant/award (A): 24,473 @ $0 | EDGAR |
| 2021-03-02 | 4 | HANTSON LUDWIG — CEO, Director | Grant/award (A): 83,725 @ $0 | EDGAR |
| 2021-03-02 | 4 | Chiniara Ellen — EVP & Chief Legal Officer | Grant/award (A): 19,321 @ $0 | EDGAR |
| 2020-12-21 | 4 | Bazarko Daniel — SVP, Controller, CAO | Option exercise (M): 13,066 @ $97.58 · Option exercise (M): 11,000 @ $140.16 · Sale (S): 9,900 @ $157.59 · Sale (S): 13,066 @ $157.76 · Sale (S): 1,100 @ $158 · Option exercise (M): 13,066 (derivative) @ $0 · +1 more | EDGAR |
| 2020-12-18 | 4 | Franchini Indrani Lall — EVP, Chief Compliance Officer | Grant/award (A): 37,965 @ $0 · Tax withholding (F): 16,925 @ $157.96 · Tax withholding (F): 2,913 @ $157.96 | EDGAR |
| 2020-12-18 | 4 | ORLOFF JOHN J — EVP, Research & Development | Grant/award (A): 40,677 @ $0 · Tax withholding (F): 18,134 @ $157.96 · Tax withholding (F): 3,261 @ $157.96 · Grant/award (A): 40 @ $93.53 | EDGAR |
| 2020-12-18 | 4 | Goff Brian — EVP & Chief Commercial Officer | Grant/award (A): 40,677 @ $0 · Tax withholding (F): 18,134 @ $157.96 · Tax withholding (F): 3,261 @ $157.96 | EDGAR |
| 2020-12-18 | 4 | HANTSON LUDWIG — CEO, Director | Grant/award (A): 162,707 @ $0 · Tax withholding (F): 72,533 @ $157.96 · Tax withholding (F): 13,059 @ $157.96 | EDGAR |
| 2020-12-18 | 4 | Chiniara Ellen — EVP & Chief Legal Officer | Grant/award (A): 37,965 @ $0 · Tax withholding (F): 16,925 @ $157.96 · Tax withholding (F): 2,988 @ $157.96 · Grant/award (A): 56 @ $95.53 | EDGAR |
Recent 8-K events — ALEXION PHARMACEUTICALS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-07-22 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-07-20 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2021-05-13 | 8-K/A | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-05-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2021-02-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALXN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs